Project Name：Repaglinide metformin
Registration Classification：3.2
Formulations and specifications ：Tablets: 1mg/500mg, 2mg/500mg
Indications：Treatment type Ⅱ diabetes which the blood sugar can not be controled by any kind of medication .
Original Research Company：Novo Nordisk
Progress：Collating information , preparing submitted to the State Bureau
Category ：Antidiabetic drugs